Literature DB >> 6166421

Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis.

U Kuhlmann, J Steurer, K Rhyner, A von Felten, J Briner, W Siegenthaler.   

Abstract

Platelet aggregation and beta-thromboglobulin levels were studied in 17 patients with the nephrotic syndrome. Thrombosis or thromboembolic complications occurred in 4 of these patients with serum albumin levels below 2 g/100 ml. Pathologic platelet aggregation assessed by estimating alpha 2-angle values derived from platelet aggregation curves was seen in the 4 patients with thromboembolic complications (alpha 2-angle 69.5 degrees +/- 10.1 degrees), whereas patients without thrombosis showed normal alpha 2-angle values (less than 30 degrees) with only one exception. In addition, patients with thromboembolic complications demonstrated significantly elevated beta-thromboglobulin levels, when compared with those not having thrombosis or thromboembolic complications (76.8 +/- 14.3 ng/ml vs 44.8 +/- 8.6 ng/ml, P less than 0.001). The decrease in serum albumin concentration showed an inverse relationship with both, alpha 2-angle values (r = -0.82, P less than 0.001) and beta-thromboglobulin levels (r = -0.83, P less than 0.001) indicating a regulatory role of serum albumin in platelet aggregation. We conclude, that altered platelet aggregation as well as hypercoagulability may be involved in the pathogenesis of thrombosis and thromboembolic complications in the course of the nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166421

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  8 in total

Review 1.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

2.  In vivo platelet activity and serum albumin concentration in nephrotic syndrome.

Authors:  F Goubran; F Maklady
Journal:  Blut       Date:  1988-07

Review 3.  Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease.

Authors:  Bryce A Kerlin; Rose Ayoob; William E Smoyer
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-16       Impact factor: 8.237

4.  Antiphospholipid syndrome: five year follow up.

Authors:  R A Asherson; E Baguley; C Pal; G R Hughes
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 5.  Nephrotic syndrome: a platelet hyperaggregability state.

Authors:  A Rasedee; B F Feldman
Journal:  Vet Res Commun       Date:  1985-07       Impact factor: 2.459

6.  Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.

Authors:  J J Zwaginga; H A Koomans; J J Sixma; T J Rabelink
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

Review 7.  Platelet abnormalities in nephrotic syndrome.

Authors:  Benedicte Eneman; Elena Levtchenko; Bert van den Heuvel; Chris Van Geet; Kathleen Freson
Journal:  Pediatr Nephrol       Date:  2015-08-13       Impact factor: 3.714

8.  Platelet functions and coagulation changes in Indian children with nephrotic syndrome.

Authors:  Aliza Mittal; Kailash Chandra Aggarwal; Sumita Saluja; Archana Aggarwal; Binit Sureka
Journal:  J Clin Diagn Res       Date:  2013-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.